"Ceci n'est pas une migraine." Cas cliniques de céphalées de diagnostic difficile.

Conference (2013, April 11)

Transcranial direct current stimulation (tDCS) of the visual cortex in migraine: a proof-of-concept study based on electrophysiological abnormalities

in Journal of Headache & Pain (2013), 14(23),

Migraine prevention with a supraorbital transcutaneous stimulator. A randomized controlled trial.

in Neurology (2013), 80

Neurostimulation et céphalées

Scientific conference (2012, December 11)

Cluster headache Award 2012: Central modulation in cluster headache patients treated with occipital nerve stimulation

in Journal of Headache & Pain (2012, September 16)

Anodal transcranial direct current stimulation over the visual cortex as a preventive treatment of migraine: a proof-of-concept study.

in Frontiers in Human Neuroscience (2012, September)

A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache

in Cephalalgia : An International Journal of Headache (2012)

Neurostimulation therapies for primary headache disorders: present and future

in Current Opinion in Neurology (2012), 25(3), 269-276

Purpose of review Most pharmacological treatments of primary headache disorders are partially effective and have cumbersome side effects. Therapies with better efficacy and tolerance are needed ... [more ▼]

Purpose of review Most pharmacological treatments of primary headache disorders are partially effective and have cumbersome side effects. Therapies with better efficacy and tolerance are needed. Neurostimulation techniques may have this potential. This is an attempt to summarize the latest clinical trial results published in the field. Recent findings Hypothalamic deep brain stimulation is effective in drug-resistant chronic cluster headache (drCCH) but not riskless. Recent anatomical MRI studies indicate that the effective stimulation sites are rather widespread. Occipital nerve stimulation (ONS) seems to be effective in up to 76% of drCCH patients and its benefit long-lasting. A minority of patients are able to abandon preventive drugs. Its mechanism of action appears nonspecific. In chronic migraine, randomized controlled trials of ONS showed recently encouraging results, but long-term studies are missing. An ongoing sham-controlled trial suggests sphenopalatine ganglion neurostimulation (SPGS) efficacy in drCCH acute treatment, but possibly also in preventive therapy. Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) modulate cortical excitability and connectivity. TMS could prevent headache when applied over the occipital cortex during the migraine aura. Repetitive TMS and tDCS have provided mixed results in a few small studies and warrant further trials. Summary Neurostimulation therapies inaugurate a new era in headache management and offer a promising alternative to medications. Future studies are necessary to provide evidence-based efficacy data, knowledge on their mode of action and information about their pharmaco-economic advantages. [less ▲]

Neurosurgery for headaches

Conference (2012, March)

Neurostimulation dans l’algie vasculaire de la face.

Conference (2011, October)